article thumbnail

Safe Sharps Handling When Dispensing Investigational Products

Advarra

Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug room or pharmacy to the clinic where the injection will be administered. Healthcare workers are frequently taught never to recap syringes after use. Needles must not be bent or sheared.

article thumbnail

Clean Bench vs Biosafety Cabinet: What’s the Difference?

Advarra

They provide sterile air to prevent environmental contamination of the investigational product and sterilize the exhaust air to prevent occupational exposure and environmental release of the drug. Work surfaces, such as the horizontal surface inside the BSCs, must be disinfected following work or spills involving biohazardous materials.

article thumbnail

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Pharmaceutical Technology

However, stopping nucleation and growth is challenging and often involves the use of biohazardous substances. Overcoming the process limitations of wet nanomilling for pharmaceutical drug substances. Further scaling-up is delicate and laborious. Free Whitepaper.